Inactive Instrument

Sector ratings Galapagos NV Euronext Bruxelles

Stocks

End-of-day quote Euronext Bruxelles
-	-

08-12	Tranche Update on Lakefront Biotherapeutics NV's Equity Buyback Plan announced on June 9, 2026.	CI
08-11	RBC Adjusts PT on Lakefront Biotherapeutics to $26 From $28, Keeps Sector Perform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LONZA GROUP AG	48.63B		AAA
REVOLUTION MEDICINES, INC.	46.3B	-	B	-	-
BEONE MEDICINES AG	41.97B		-
IQVIA HOLDINGS INC.	39.51B		AAA
CELLTRION, INC.	31.75B		A
MEDPACE HOLDINGS, INC.	16.48B		BBB
ASCENDIS PHARMA A/S	16.34B	-	-	-	-
EUROFINS SCIENTIFIC SE	14B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	13.33B		AA
ICON PUBLIC LIMITED COMPANY	12.89B		AAA
PHARMARON BEIJING CO., LTD.	12.68B		AA
BIO-TECHNE CORPORATION	11.25B		AA
ABIVAX	10.27B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	10.33B	-	B	-	-
PROTAGONIST THERAPEUTICS, INC.	10.18B		BB		-
APOGEE THERAPEUTICS, INC.	10.15B	-	B	-	-
KYMERA THERAPEUTICS, INC.	10.09B	-	BBB	-	-
IONIS PHARMACEUTICALS, INC.	9.91B	-	A	-	-
TEMPUS AI, INC.	8.91B		A		-
Average	19.73B		A
Weighted average by Cap.			A

×